Articles with public access mandates - Alessandra SolariLearn more
Not available anywhere: 6
Iron‐related MRI images in patients with pantothenate kinase–associated neurodegeneration (PKAN) treated with deferiprone: Results of a phase II pilot trial
G Zorzi, F Zibordi, L Chiapparini, E Bertini, L Russo, A Piga, F Longo, ...
Movement Disorders 26 (9), 1755-1759, 2011
Mandates: Canadian Institutes of Health Research
Erythropoietin in Friedreich ataxia: no effect on frataxin in a randomized controlled trial
C Mariotti, R Fancellu, S Caldarazzo, L Nanetti, D Di Bella, M Plumari, ...
Movement Disorders 27 (3), 446-449, 2012
Mandates: Government of Spain
Responsiveness of clinical outcome measures in Charcot− Marie− Tooth disease
G Piscosquito, MM Reilly, A Schenone, GM Fabrizi, T Cavallaro, ...
European Journal of Neurology 22 (12), 1556-1563, 2015
Mandates: Fondazione Telethon, Italy, UK Medical Research Council, National Institute …
Pain and small fiber function in Charcot–Marie–Tooth disease type 1A
M Laurà, EJ Hutton, J Blake, MP Lunn, Z Fox, D Pareyson, A Solari, ...
Muscle & Nerve 50 (3), 366-371, 2014
Mandates: US National Institutes of Health, UK Medical Research Council, National …
Postpartum relapse risk in multiple sclerosis: a systematic review and meta-analysis
C Schubert, L Steinberg, J Peper, C Ramien, K Hellwig, S Köpke, A Solari, ...
Journal of Neurology, Neurosurgery & Psychiatry 94 (9), 718-725, 2023
Mandates: German Research Foundation, Federal Ministry of Education and Research, Germany
Motherhood choice in multiple sclerosis (MoMS) development and piloting of patient-reported outcome measures
L Steinberg, J Peper, S Köpke, A Solari, A Giordano, SM Gold, K Hellwig, ...
Multiple Sclerosis and Related Disorders 63, 103831, 2022
Mandates: German Research Foundation
Available somewhere: 14
Ascorbic acid in Charcot–Marie–Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial
D Pareyson, MM Reilly, A Schenone, GM Fabrizi, T Cavallaro, L Santoro, ...
The Lancet Neurology 10 (4), 320-328, 2011
Mandates: Fondazione Telethon, Italy
Unmet needs of people with severe multiple sclerosis and their carers: qualitative findings for a home-based intervention
C Borreani, E Bianchi, E Pietrolongo, I Rossi, S Cilia, M Giuntoli, ...
PloS one 9 (10), e109679, 2014
Mandates: Government of Italy
Cellular prion protein controls stem cell-like properties of human glioblastoma tumor-initiating cells
A Corsaro, A Bajetto, S Thellung, G Begani, V Villa, M Nizzari, ...
Oncotarget 7 (25), 38638, 2016
Mandates: Government of Italy
Azathioprine versus beta interferons for relapsing-remitting multiple sclerosis: a multicentre randomized non-inferiority trial
L Massacesi, I Tramacere, S Amoroso, MA Battaglia, MD Benedetti, ...
PLoS One 9 (11), e113371, 2014
Mandates: Government of Italy
EAN guideline on palliative care of people with severe, progressive multiple sclerosis
A Solari, A Giordano, J Sastre-Garriga, S Köpke, AC Rahn, I Kleiter, ...
Journal of palliative medicine 23 (11), 1426-1443, 2020
Mandates: Multiple Sclerosis Society, UK
Nerve conduction velocity in CMT 1A: what else can we tell?
F Manganelli, C Pisciotta, MM Reilly, S Tozza, A Schenone, GM Fabrizi, ...
European journal of neurology 23 (10), 1566-1571, 2016
Mandates: US National Institutes of Health, Fondazione Telethon, Italy, National …
Selected items from the Charcot-Marie-Tooth (CMT) Neuropathy Score and secondary clinical outcome measures serve as sensitive clinical markers of disease severity in CMT1A patients
M Mannil, A Solari, A Leha, AL Pelayo-Negro, J Berciano, ...
Neuromuscular disorders 24 (11), 1003-1017, 2014
Mandates: UK Medical Research Council, National Institute for Health Research, UK …
In vitro and in vivo characterization of stem-like cells from canine osteosarcoma and assessment of drug sensitivity
M Gatti, A Solari, A Pattarozzi, C Campanella, S Thellung, L Maniscalco, ...
Experimental cell research 363 (1), 48-64, 2018
Mandates: Government of Italy
Biomarkers predict outcome in Charcot-Marie-Tooth disease 1A
R Fledrich, M Mannil, A Leha, C Ehbrecht, A Solari, AL Pelayo-Negro, ...
Journal of Neurology, Neurosurgery & Psychiatry 88 (11), 941-952, 2017
Mandates: US National Institutes of Health, Research Foundation (Flanders), German …
PMP22 messenger RNA levels in skin biopsies: testing the effectiveness of a Charcot–Marie–Tooth 1A biomarker
L Nobbio, D Visigalli, D Radice, E Fiorina, A Solari, G Lauria, MM Reilly, ...
Brain 137 (6), 1614-1620, 2014
Mandates: Fondazione Telethon, Italy, UK Medical Research Council, Government of Italy
Patient and caregiver involvement in the formulation of guideline questions: findings from the European Academy of Neurology guideline on palliative care of people with severe …
S Köpke, A Giordano, S Veronese, AC Rahn, I Kleiter, ...
European Journal of Neurology 26 (1), 41-50, 2019
Mandates: Multiple Sclerosis Society, UK
Is overwork weakness relevant in Charcot–Marie–Tooth disease?
G Piscosquito, MM Reilly, A Schenone, GM Fabrizi, T Cavallaro, ...
Journal of Neurology, Neurosurgery & Psychiatry 85 (12), 1354-1358, 2014
Mandates: Fondazione Telethon, Italy, UK Medical Research Council, Government of Italy
Use of Rasch analysis to refine a patient-reported questionnaire on satisfaction with communication of the multiple sclerosis diagnosis
A Solari, M Grzeda, A Giordano, K Mattarozzi, R D’Alessandro, A Simone, ...
Multiple Sclerosis Journal 20 (9), 1224-1233, 2014
Mandates: Government of Italy
Italian cross-cultural adaptation of the Quality of Communication questionnaire and the 4-item advance care planning engagement questionnaire
L De Panfilis, S Veronese, M Perin, M Cascioli, M Farinotti, P Kruger, ...
PloS one 18 (3), e0282960, 2023
Mandates: US National Institutes of Health, Government of Italy
Publication and funding information is determined automatically by a computer program